DPYSL5 and Parkinson disease: ▪ Movement disorders such as chorea, dyskinesias, dystonias, or myoclonus (associated with multiple antibodies including anti- NMDAR, CASPR2, LGI1,Ri, Hu, or CV2/CRMP5); and rarely parkinsonism (associated with anti-Ri, NMDAR, LGI1, and D2R) (78).